PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Multiple Sacituzumab Tirumotecan (sac-TMT) Studies Selected as LBAs at ESMO 2026, OptiTROP-Lung04 and OptiTROP-Lung06 to be Presented in the Lung Cancer Session
2026-09-22T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
BoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset
2026-09-22T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Bestzyme Launches World's First Dedicated, Automated Smart Production Line for Sweet Proteins in Jinan
2026-09-22T    Agriculture   Biotechnology   Chemical   Food/Beverages 
Ivonescimab First-Line Biliary Tract Cancer Phase III Overall Survival Data Selected as ESMO Late-Breaking Abstract; Nearly 30 Akeso Studies to Be Presented at ESMO 2026
2026-09-22T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
The Next Chapter of B7-H3: From Systemic Disease to the Brain
2026-09-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
WuXi XDC Celebrates GMP Release of Singapore Site, Ushering in a New Era of Global Expansion
2026-09-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Clean Bio Korea to Showcase Indonesia-Validated Air-Fit at Hospital Expo 2026
2026-09-21T    Biotechnology   Health Care/Hospital   Infectious Disease Control 
Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
2026-09-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Antengene Announces First Patient Dosed in Pivotal Phase III CLINCH-3 Study of ATG-022
2026-09-21T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia
2026-09-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.